FDA Expected To Approve Esketamine Nasal Spray For Depression

By Jon Hamilton

Published March 4, 2019 at 7:41 PM EST

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.

See stories by Jon Hamilton

National & International News

One week into post-Assad rule in Syria - a view from Damascus

Scott Detrow

Morning Edition host Leila Fadel reports from Damascus, in the first week in a half-century that the Assad family did not rule the country.
This former Trump official doesn't want a pardon from President Biden

Scott Detrow
'The Nickel Boys' film adaptation is 'stunningly effective'

Bob Mondello

Filmmaker RaMell Ross employs a unique visual strategy to tell the story of two teens trying to survive a racist Jim Crow-era reform school. The film is adapted from Colson Whitehead's Pulitzer-winning novel.